T. Meng , X. Fang , L. Zhang , D. Hou , Q. Zhang , Z. Zuo , S. Zhu
{"title":"基于miR-139、核因子-红细胞2相关因子2和miR-7的胃癌患者术后生存预后Nomogram构建与验证","authors":"T. Meng , X. Fang , L. Zhang , D. Hou , Q. Zhang , Z. Zuo , S. Zhu","doi":"10.1016/j.clon.2025.103913","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>To explore the relationship among the expression levels of miR-139, nuclear factor erythroid2-related factor 2 (NRF2) and miR-7 and postoperative survival in patients with gastric cancer, and to construct a nomogram prediction model.</div></div><div><h3>Materials and methods</h3><div>The expression levels of miR-139 and miR-7 were detected using real-time fluorescence quantitative polymerase chain reaction (PCR), while NRF2 expression was assessed by immunohistochemistry. The associations between these biomarkers and clinicopathological features as well as postoperative survival were analyzed. Multivariate cox regression analysis was used to identify independent prognostic factors, and a nomogram prediction model was constructed.</div></div><div><h3>Results</h3><div>There were statistically significant differences in tumour diameter, tumour differentiation, infiltration depth, lymph node metastasis, TNM staging, miR-139 level, NRF2 score, and miR-7 level between survival group and death group (<em>P</em> < 0.05). The multivariate Cox regression analysis showed that lymph node metastasis, TNM stage, and miR-139 were independent risk factors, while NRF2 and miR-7 were independent protective factors. The nomogram prediction model achieved an area under the curve (AUC) of 0.959 (95% CI: 0.933-0.985) in predicting postoperative survival factors in gastric cancer patients. The results of calibration chart clearly show that the predicted values of the model are highly consistent with the actual observed values, and its C-index value is 0.959. In addition, the results of decision curve analysis (DCA) further verified the good practicability of the model in clinical application.</div></div><div><h3>Conclusion</h3><div>miR-139, NRF2, and miR-7 are independent influencing factors on postoperative survival of patients with gastric cancer. Based on this, the nomogram prediction model shows good prediction performance in patients with gastric cancer.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"46 ","pages":"Article 103913"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Construction and Validation of a Nomogram for Postoperative Survival Prognosis in Gastric Cancer Patients Based on miR-139, Nuclear Factor Erythroid2-Related Factor 2, and miR-7\",\"authors\":\"T. Meng , X. Fang , L. Zhang , D. Hou , Q. Zhang , Z. Zuo , S. Zhu\",\"doi\":\"10.1016/j.clon.2025.103913\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><div>To explore the relationship among the expression levels of miR-139, nuclear factor erythroid2-related factor 2 (NRF2) and miR-7 and postoperative survival in patients with gastric cancer, and to construct a nomogram prediction model.</div></div><div><h3>Materials and methods</h3><div>The expression levels of miR-139 and miR-7 were detected using real-time fluorescence quantitative polymerase chain reaction (PCR), while NRF2 expression was assessed by immunohistochemistry. The associations between these biomarkers and clinicopathological features as well as postoperative survival were analyzed. Multivariate cox regression analysis was used to identify independent prognostic factors, and a nomogram prediction model was constructed.</div></div><div><h3>Results</h3><div>There were statistically significant differences in tumour diameter, tumour differentiation, infiltration depth, lymph node metastasis, TNM staging, miR-139 level, NRF2 score, and miR-7 level between survival group and death group (<em>P</em> < 0.05). The multivariate Cox regression analysis showed that lymph node metastasis, TNM stage, and miR-139 were independent risk factors, while NRF2 and miR-7 were independent protective factors. The nomogram prediction model achieved an area under the curve (AUC) of 0.959 (95% CI: 0.933-0.985) in predicting postoperative survival factors in gastric cancer patients. The results of calibration chart clearly show that the predicted values of the model are highly consistent with the actual observed values, and its C-index value is 0.959. In addition, the results of decision curve analysis (DCA) further verified the good practicability of the model in clinical application.</div></div><div><h3>Conclusion</h3><div>miR-139, NRF2, and miR-7 are independent influencing factors on postoperative survival of patients with gastric cancer. Based on this, the nomogram prediction model shows good prediction performance in patients with gastric cancer.</div></div>\",\"PeriodicalId\":10403,\"journal\":{\"name\":\"Clinical oncology\",\"volume\":\"46 \",\"pages\":\"Article 103913\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0936655525001682\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0936655525001682","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Construction and Validation of a Nomogram for Postoperative Survival Prognosis in Gastric Cancer Patients Based on miR-139, Nuclear Factor Erythroid2-Related Factor 2, and miR-7
Aim
To explore the relationship among the expression levels of miR-139, nuclear factor erythroid2-related factor 2 (NRF2) and miR-7 and postoperative survival in patients with gastric cancer, and to construct a nomogram prediction model.
Materials and methods
The expression levels of miR-139 and miR-7 were detected using real-time fluorescence quantitative polymerase chain reaction (PCR), while NRF2 expression was assessed by immunohistochemistry. The associations between these biomarkers and clinicopathological features as well as postoperative survival were analyzed. Multivariate cox regression analysis was used to identify independent prognostic factors, and a nomogram prediction model was constructed.
Results
There were statistically significant differences in tumour diameter, tumour differentiation, infiltration depth, lymph node metastasis, TNM staging, miR-139 level, NRF2 score, and miR-7 level between survival group and death group (P < 0.05). The multivariate Cox regression analysis showed that lymph node metastasis, TNM stage, and miR-139 were independent risk factors, while NRF2 and miR-7 were independent protective factors. The nomogram prediction model achieved an area under the curve (AUC) of 0.959 (95% CI: 0.933-0.985) in predicting postoperative survival factors in gastric cancer patients. The results of calibration chart clearly show that the predicted values of the model are highly consistent with the actual observed values, and its C-index value is 0.959. In addition, the results of decision curve analysis (DCA) further verified the good practicability of the model in clinical application.
Conclusion
miR-139, NRF2, and miR-7 are independent influencing factors on postoperative survival of patients with gastric cancer. Based on this, the nomogram prediction model shows good prediction performance in patients with gastric cancer.
期刊介绍:
Clinical Oncology is an International cancer journal covering all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy. Papers, editorials and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews.